Artwork

Content provided by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

JAMA: 2009-12-16, Vol. 302, No. 23, Author in the Room™ Audio Interview

53:00
 
Share
 

Manage episode 337237136 series 3380326
Content provided by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Interview with Frank Davidoff, MD, author of Heterogeneity Is Not Always Noise. Summary Points: 1. A clinical trial is a powerful tool for showing whether an intervention works, but the heterogeneity of trial participants means it may be a mistake to assume that the overall (or group) benefit of an intervention found in such a trial is the same for every participant. 2. The absolute benefit of an intervention is greater for trial participants-and for patients generally-whose baseline risk for a bad outcome is high than it is for those whose baseline risk is low. 3. A quality improvement program in any one organization is like an individual patient in the sense that it is highly complex, it is unstable (ie, changes over time), and its local circumstances are unique. It is thus hard-although not impossible-to judge whether a quality improvement program in any particular setting actually works and to know whether it would work elsewhere.
  continue reading

97 episodes

Artwork
iconShare
 
Manage episode 337237136 series 3380326
Content provided by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Copyright © 2019 American Medical Association. All Rights Reserved. and JAMA Network or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Interview with Frank Davidoff, MD, author of Heterogeneity Is Not Always Noise. Summary Points: 1. A clinical trial is a powerful tool for showing whether an intervention works, but the heterogeneity of trial participants means it may be a mistake to assume that the overall (or group) benefit of an intervention found in such a trial is the same for every participant. 2. The absolute benefit of an intervention is greater for trial participants-and for patients generally-whose baseline risk for a bad outcome is high than it is for those whose baseline risk is low. 3. A quality improvement program in any one organization is like an individual patient in the sense that it is highly complex, it is unstable (ie, changes over time), and its local circumstances are unique. It is thus hard-although not impossible-to judge whether a quality improvement program in any particular setting actually works and to know whether it would work elsewhere.
  continue reading

97 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide